about
Use of fluid-ventilated, gas-permeable scleral lens for management of severe keratoconjunctivitis sicca secondary to chronic graft-versus-host diseaseAcute promyelocytic leukemia with PML-RARA fusion on i(17q) and therapy-related acute myeloid leukemia.Biological characteristics of megakaryocytes: specific lineage commitment and associated disorders.Panobinostat in combination with bortezomib in patients with relapsed or refractory peripheral T-cell lymphoma: an open-label, multicentre phase 2 trial.Clinicopathological features and outcome of chronic lymphocytic leukaemia in Chinese patients.Mesenchymal stem cells secreting angiopoietin-like-5 support efficient expansion of human hematopoietic stem cells without compromising their repopulating potentialEffect of cord blood processing on transplantation outcomes after single myeloablative umbilical cord blood transplantationImmunogenicity of engineered antibodies.Mixed Phenotype Acute Leukemia with Low Hypodiploidy in a Pediatric Patient.Intercellular cytosolic transfer correlates with mesenchymal stromal cell rescue of umbilical cord blood cell viability during ex vivo expansionA meta-analysis of unrelated donor umbilical cord blood transplantation versus unrelated donor bone marrow transplantation in adult and pediatric patients.Autologous haematopoietic stem cell transplantation for the treatment of multiple sclerosis.Outpatient-based therapy of oral fludarabine and subcutaneous alemtuzumab for asian patients with relapsed/refractory chronic lymphocytic leukemia.Role of Surveillance Imaging in Patients With Peripheral T-Cell Lymphoma.A phase I/II clinical trial of autologous cytokine-induced killer cells as adjuvant immunotherapy for acute and chronic myeloid leukemia in clinical remission.Safety of Living Donation of Hematopoietic Stem Cells.Expansion of human cord blood hematopoietic stem cells for transplantation.Protective role of functionalized single walled carbon nanotubes enhance ex vivo expansion of hematopoietic stem and progenitor cells in human umbilical cord blood.Studies of Wilms' Tumor (WT1) Gene Expression in Adult Acute Leukemias in SingaporeAn abnormal nonhyperdiploid karyotype is a significant adverse prognostic factor for multiple myeloma in the bortezomib era.Effect of anti-CD52 antibody alemtuzumab on ex-vivo culture of umbilical cord blood stem cells.WPSS is a strong prognostic indicator for clinical outcome of allogeneic transplant for myelodysplastic syndrome in Southeast Asian patients.Impact of postgrafting immunosuppressive regimens on nonrelapse mortality and survival after nonmyeloablative allogeneic hematopoietic stem cell transplant using the fludarabine and low-dose total-body irradiation 200-cGy.What We Learned From Plasma BK-Virus Monitoring in Allogeneic Hematopoietic Transplant Recipients.MNGO-05IMAGING AND EXTENT OF SURGICAL RESECTION PREDICT RISK OF MENINGIOMA RECURRENCE BETTER THAN WHO HISTOPATHOLOGICAL GRADE.Blood donation and beyond.The impact of time from diagnosis to treatment in diffuse large B-cell lymphoma.A cluster of Epoetin-associated pure red cell aplasia: clinical features and the possible association of HLA-DRB1*12:02.Electrospun nanofiber scaffolds for rapid and rich capture of bone marrow-derived hematopoietic stem cells.Pre-transplant achievement of negativity in minimal residual disease and French-American-British L1 morphology predict superior outcome after allogeneic transplant for Philadelphia chromosome positive acute lymphoblastic leukemia: an analysis of SouMulticenter study of comparative outcomes of hematopoietic stem cell transplant for peripheral T cell lymphoma and natural killer/T-cell lymphoma
P50
Q24682181-7D37BEC3-9FF4-4254-8FA1-5A57DC2FCD65Q33366338-5C53931D-9D94-4150-A404-171A957968FDQ33371347-D7155010-72CA-435E-BE10-4F785DC9D8B9Q33428575-10CBD2C5-232C-4159-993B-41ECDF81D876Q33648906-50E43262-A370-45E0-8EC7-98DA9B67D7A2Q35143196-B1B85104-2440-4FAB-8096-43F30C870578Q35177492-2829192B-C3BE-403A-A38B-C1A9734005ADQ36105046-7A1AD4A7-B5CF-4ED1-B65C-845A0C577561Q36224426-E4D8747B-7F43-4F79-A356-6218329218DCQ36359556-BAD7E91A-F6E0-41C8-94F6-C7E2A3BC19D3Q36768636-F19109FA-2A84-4196-AEA5-325516051DBEQ36863570-1906D27E-FABB-44B2-9C9F-DD1234B335C5Q37423850-88E910A4-1D0C-45F3-9AE3-22B7256640CEQ38706816-2CE686A2-EFCA-4C0B-B72D-213907529C85Q40280519-50166850-1697-46AD-9B43-35CCDCB51433Q40691128-426F09D7-5ADD-405D-8577-A5FF0D74ADD3Q41976345-5C473BAE-56DA-4A81-8400-4836333631B7Q42439438-53BE31B1-B33C-468E-B19C-421351CFD891Q42617564-1EF6E9BC-43F7-4C8C-B548-F4D534D31285Q42933024-FD0CB2BE-6041-40EF-B4CA-B8474194F67CQ43243754-38B4F461-1C43-4CAB-8138-2B78683A23BEQ44066797-582FD363-5A62-4EF2-B0E3-81AB96AE1535Q44488573-5024C2DC-9E6D-4A80-AC5F-B12E53C23BA5Q45337482-93D10F4E-4F6C-460B-A698-E476CB7A9664Q45833760-914B88A1-EBFB-4E6F-B8FF-E6F086F42B90Q48625871-B8C1EE48-E3F0-4D50-B1C1-8ABFB818749EQ49975570-FAD84DDB-BD18-48A4-8577-7710B7AC2250Q50236570-9EC1D0CB-9309-48F8-A672-B1233915F2D5Q50803293-9F9552C9-9E30-4F7A-A431-087BA74B7B38Q53026373-1C843B7B-3D0B-4675-A0D6-064EC038CE5FQ57717851-D6A81186-BCA7-44D9-B790-AF51EE5978B8
P50
name
William Ying Khee Hwang
@ast
William Ying Khee Hwang
@en
William Ying Khee Hwang
@es
William Ying Khee Hwang
@nl
type
label
William Ying Khee Hwang
@ast
William Ying Khee Hwang
@en
William Ying Khee Hwang
@es
William Ying Khee Hwang
@nl
prefLabel
William Ying Khee Hwang
@ast
William Ying Khee Hwang
@en
William Ying Khee Hwang
@es
William Ying Khee Hwang
@nl